Related Experiment Video
Updated: Aug 28, 2026
Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
Xylitol-Containing Nasal Irrigation or Nebulization in Postoperative Sinonasal Care: A Systematic Review and
Mohamed Saad Rakab1, Yasir Majhud S Alzahrani2, Abdulaziz Muhayya Alotaibi3
1Department of Clinical Research and Scientific Services, Publication Hub, Riyadh, Saudi Arabia.
Background:
Xylitol, a five-carbon polyol with antibiofilm effects, is increasingly added to postoperative sinonasal irrigations, yet its advantage over saline remains uncertain.
Methods:
We systematically reviewed comparative studies evaluating xylitol-containing nasal solutions after ESS, septoplasty, or turbinate surgery. Searches spanned PubMed, Scopus, Web of Science, and CENTRAL from inception to 18 June 2026. Outcomes included patient-reported symptoms (SNOT-20/22, NOSE, VAS), endoscopic healing, and safety. Random-effects meta-analysis pooled effects as mean differences (MD) or standardized mean differences (SMD); certainty was appraised with GRADE.
Results:
Eight studies met eligibility. Xylitol showed no clear overall advantage on SNOT-20/22 (SMD -0.49, 95% CI -1.12 to 0.14; p = 0.107; I2 = 72.9%). The effect was larger yet heterogeneous post-ESS (SMD -0.79, 95% CI -1.99 to 0.41), while non-ESS effects centred on no difference (SMD -0.09, 95% CI -0.45 to 0.26). Excluding Lin 2017 resolved most heterogeneity and significantly favoured xylitol (SMD -0.27, 95% CI -0.47 to -0.06; p = 0.0098; I2 = 24.2%). VAS score showed modest yet statistically significant improvement with xylitol (MD -1.16 points, 95% CI -2.30 to -0.03; p = 0.045). NOSE showed no overall benefit (MD -4.18, 95% CI -13.04 to 4.68; p = 0.2299); non-ESS improved slightly (MD -1.17, 95% CI -2.08 to -0.26; p = 0.0387), while ESS was heterogeneous and uncertain. Endoscopic scores were not significantly different (SMD -0.21, 95% CI -0.51 to 0.08; p = 0.1157).
Conclusions:
Xylitol-containing postoperative irrigations may provide modest symptomatic benefit in selected postoperative populations, but the evidence remains low to very low certainty and does not establish a reliable clinically important SNOT-22 benefit. Larger, multicentre RCTs with standardized dosing/delivery and head-to-head comparators are needed to define candidates, optimal regimens, and durability of benefit.
Related Concept Videos
01:29Suctioning the Nasopharyngeal Airway
Equipment Required
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:30Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
01:26Tonsillitis II: Management
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:29Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils, connected...